Quetiapine Formulation Patent Obvious – U.K. High Court
On March 22, 2012, the U.K. High Court of Justice, Chancery Division held that AstraZeneca’s patent covering an sustained release formulation of... Read More
Centocor’s ustekinumab infringes Abbott’s human IL-2 antibody patents – US District Judge
On March 9, 2012, the District Court of Massachusetts found, within a series of competing summary judgement motions, that Centocor’s ustekinumab (STELARA)... Read More